Rune Midgard

3.5k total citations
66 papers, 2.4k citations indexed

About

Rune Midgard is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Rune Midgard has authored 66 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pathology and Forensic Medicine, 17 papers in Rheumatology and 13 papers in Neurology. Recurrent topics in Rune Midgard's work include Multiple Sclerosis Research Studies (48 papers), Peripheral Neuropathies and Disorders (10 papers) and Systemic Lupus Erythematosus Research (8 papers). Rune Midgard is often cited by papers focused on Multiple Sclerosis Research Studies (48 papers), Peripheral Neuropathies and Disorders (10 papers) and Systemic Lupus Erythematosus Research (8 papers). Rune Midgard collaborates with scholars based in Norway, United States and Spain. Rune Midgard's co-authors include Trond Riise, Harald Nyland, Kjell‐Morten Myhr, Øivind Torkildsen, Trygve Holmøy, Jan Aarseth, Nina Grytten, M. Grønning, Stig Wergeland and Harald Hovdal and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Rune Midgard

64 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rune Midgard Norway 30 1.7k 602 407 403 301 66 2.4k
Kjetil Bjørnevik United States 22 1.3k 0.8× 627 1.0× 286 0.7× 550 1.4× 471 1.6× 62 2.7k
Suzanne Hodgkinson Australia 30 1.1k 0.7× 449 0.7× 252 0.6× 1.2k 3.0× 371 1.2× 110 2.9k
Michael J. Olek United States 22 2.2k 1.4× 410 0.7× 448 1.1× 940 2.3× 427 1.4× 38 3.2k
Abdorreza Naser Moghadasi Iran 21 1.1k 0.7× 628 1.0× 227 0.6× 218 0.5× 135 0.4× 224 1.8k
Helle Bach Søndergaard Denmark 26 758 0.5× 155 0.3× 214 0.5× 424 1.1× 277 0.9× 76 1.7k
Marianna Cortese United States 18 948 0.6× 378 0.6× 222 0.5× 427 1.1× 357 1.2× 44 2.1k
Lahiru Handunnetthi United Kingdom 20 1.4k 0.8× 410 0.7× 223 0.5× 661 1.6× 270 0.9× 41 2.9k
J. S. Burks United States 20 955 0.6× 334 0.6× 193 0.5× 303 0.8× 166 0.6× 42 1.7k
Ezio Paolino Italy 25 372 0.2× 474 0.8× 164 0.4× 261 0.6× 143 0.5× 53 1.6k
Bruce F. Bebo United States 31 935 0.6× 211 0.4× 444 1.1× 2.1k 5.2× 429 1.4× 61 3.7k

Countries citing papers authored by Rune Midgard

Since Specialization
Citations

This map shows the geographic impact of Rune Midgard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rune Midgard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rune Midgard more than expected).

Fields of papers citing papers by Rune Midgard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rune Midgard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rune Midgard. The network helps show where Rune Midgard may publish in the future.

Co-authorship network of co-authors of Rune Midgard

This figure shows the co-authorship network connecting the top 25 collaborators of Rune Midgard. A scholar is included among the top collaborators of Rune Midgard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rune Midgard. Rune Midgard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aase, Audun, et al.. (2024). Detection of Neoehrlichia mikurensis in 11 persons who attribute their persistent health complaints to a tick-borne disease. Ticks and Tick-borne Diseases. 16(1). 102391–102391.
2.
Wesnes, Kristin, Kjell‐Morten Myhr, Trond Riise, et al.. (2021). Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis. Multiple Sclerosis and Related Disorders. 50. 102801–102801. 15 indexed citations
3.
Grytten, Nina, Kjell‐Morten Myhr, Elisabeth Gulowsen Celius, et al.. (2021). Incidence of cancer in multiple sclerosis before and after the treatment era– a registry- based cohort study. Multiple Sclerosis and Related Disorders. 55. 103209–103209. 19 indexed citations
4.
Morsund, Åse Hagen, Hanne Ellekjær, Arne Gramstad, et al.. (2020). Factors influencing employment after minor stroke and NSTEMI. Journal of Stroke and Cerebrovascular Diseases. 29(9). 105036–105036. 4 indexed citations
5.
Morsund, Åse Hagen, Hanne Ellekjær, Arne Gramstad, et al.. (2019). Cognitive and Emotional Impairment after Minor Stroke and Non-ST-Elevation Myocardial Infarction (NSTEMI): A Prevalence Study. Stroke Research and Treatment. 2019. 1–9. 11 indexed citations
6.
Myhr, Kjell‐Morten, Trygve Holmøy, Jūratė Šaltytė Benth, et al.. (2018). Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis. Journal of Neuroimmunology. 323. 73–77. 16 indexed citations
7.
Røsjø, Egil, Kjell‐Morten Myhr, Kristin I. Løken-Amsrud, et al.. (2015). Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. Journal of Neuroimmunology. 280. 21–28. 14 indexed citations
8.
Myhr, Kjell‐Morten, Trygve Holmøy, Jūratė Šaltytė Benth, et al.. (2015). Body mass index influence interferon-beta treatment response in multiple sclerosis. Journal of Neuroimmunology. 288. 92–97. 50 indexed citations
9.
Holmøy, Trygve, Kristin I. Løken-Amsrud, S. J. Bakke, et al.. (2013). Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity. PLoS ONE. 8(9). e75021–e75021. 29 indexed citations
10.
Løken-Amsrud, Kristin I., Trygve Holmøy, S. J. Bakke, et al.. (2012). Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment. Neurology. 79(3). 267–273. 90 indexed citations
11.
Torkildsen, Øivind, Stig Wergeland, S. J. Bakke, et al.. (2012). ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study). Archives of Neurology. 69(8). 1044–51. 110 indexed citations
12.
Maniaol, Angelina, Ahmed Elsais, Åslaug Rudjord Lorentzen, et al.. (2012). Late Onset Myasthenia Gravis Is Associated with HLA DRB1*15:01 in the Norwegian Population. PLoS ONE. 7(5). e36603–e36603. 97 indexed citations
13.
Midgard, Rune, Eystein Glattre, M. Grønning, et al.. (2009). Multiple sclerosis and cancer in Norway A retrospective cohort study. Acta Neurologica Scandinavica. 93(6). 411–415. 51 indexed citations
14.
Myhr, Kjell‐Morten, P. Frost, M. Grønning, et al.. (2009). Absence of HTLV-1 related sequences in MS from high prevalence areas in Western Norway. Acta Neurologica Scandinavica. 89(1). 65–68. 1 indexed citations
15.
Ljøstad, Unn, Eirik Skogvoll, Randi Eikeland, et al.. (2008). Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. The Lancet Neurology. 7(8). 690–695. 161 indexed citations
16.
Midgard, Rune, Trond Riise, Cecilie Svanes, Gunnar Kvåle, & Harald Nyland. (1996). Incidence of multiple sclerosis in More and Romsdal, Norway from 1950 to 1991. Brain. 119(1). 203–211. 58 indexed citations
17.
Midgard, Rune, et al.. (1996). Impairment, disability and handicap in multiple sclerosis A cross-sectional study in an incident cohort in M�re and Romsdal County, Norway. Journal of Neurology. 243(4). 337–344. 41 indexed citations
18.
Grønning, Marit, Trond Riise, Gunnar Kvåle, et al.. (1993). Infections in Childhood and Adolescence in Multiple Sclerosis. Neuroepidemiology. 12(2). 61–69. 27 indexed citations
19.
Midgard, Rune, et al.. (1989). Symptomatic hemidystonia of delayed onset. Magnetic resonance demonstration of pathology in the putamen and the caudate nucleus. Acta Neurologica Scandinavica. 79(1). 27–31. 14 indexed citations
20.
Wester, Knut, et al.. (1989). Multicystic syringomyelia treated with a single, non-valved syringoperitoneal shunt: Fast and near-complete MRI normalization. Acta Neurochirurgica. 98(3-4). 148–152. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kjetil Bjørnevik Breakdown of academic impact, for papers by Suzanne Hodgkinson Breakdown of academic impact, for papers by Michael J. Olek Breakdown of academic impact, for papers by Abdorreza Naser Moghadasi Breakdown of academic impact, for papers by Helle Bach Søndergaard Breakdown of academic impact, for papers by Marianna Cortese Breakdown of academic impact, for papers by Lahiru Handunnetthi Breakdown of academic impact, for papers by J. S. Burks Breakdown of academic impact, for papers by Ezio Paolino Breakdown of academic impact, for papers by Bruce F. Bebo
Rankless by CCL
2026